[5]JungHA,LimJ,ChoiYL,etal.Clinical,pathological,andmolecularprognosticfactorsinpatientswithearly-stageEGFRmutantNSCLC[publishedonlineaheadofprint,2022Jul15].ClinCancerRes.2022;CCR-22-0879.doi:10.1158/1078-0432.CCR-22-0879
[6]YatabeY,KosakaT,TakahashiT,MitsudomiT.EGFRmutationisspecificforterminalrespiratoryunittypeadenocarcinoma.AmJSurgPathol.2005;29(5):633-639.doi:10.1097/01.pas.0000157935.28066.35
[8]KimMH,ChoJS,KimY,LeeCH,LeeMK,ShinDH.DiscriminatingbetweenTerminal-andNon-TerminalRespiratoryUnit-TypeLungAdenocarcinomaBasedonMicroRNAProfiles.PLoSOne.2016;11(8):e0160996.Published2016Aug30.doi:10.1371/journal.pone.0160996
責任編輯丨譚碩

• 肺癌|「前沿」DZD9008治療EGFR 20 ins肺癌療效顯著：部分緩解率100%
• 媽媽將女兒養的魚做了菜，女兒嚎啕大哭，當女兒吃魚時畫風突變
• |奧拉帕尼治療BRCA突變、HER2陰性乳腺癌的臨床數據及不良反應
• 兒童腦干H3K27M突變型彌漫性中線膠質細胞瘤臨床特點
• 小伙突變“小黃人”，醫生提醒：這個習慣要改